Free Webex Call
Global optical biopsy market value is anticipated to grow with an impressive CAGR during the forecast years on the backbone of technological advancement in diagnostic medicine. Growing demand for highly defined imaging and 3D visualization of the endoscopic diagnostic surface for the expert to identify and diagnose the condition with clear details, further drives the growth of the global optical biopsy market in the upcoming five years. Growing instances of chronic diseases and infectious diseases that demand detailed visualization for efficient diagnostic and timely treatment advance the growth of the global optical biopsy market in the next five years. Growing demand for non-invasive and minimally invasive diagnostic procedures further supports the growth of the global optical biopsy market in the future five years.Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The term “optical biopsy” refers to methods that use the properties of light to enable the operator to make an instant diagnosis at endoscopy, previously possible only by using histological or cytological analysis. Endoscopic diagnosis relies heavily on the ability of the operator to visualize abnormal patterns in the image created by light reflected from the mucosal surface of the gastrointestinal tract. Some of the major optical biopsy techniques for diagnosis include fluorescence endoscopy, optical coherence tomography, confocal micro-endoscopy, and molecular imaging.
Growing Demand For Endoscopic Diagnosis Drives Market Growth
A surge in the instances of chronic diseases mostly in the gastrointestinal tract like peptic ulcer disease, gastritis, gastroenteritis, celiac disease, Crohn's disease, gallstones, fecal incontinence, etc. drives the growth of the global optical biopsy market in the upcoming five years. Endoscopic diagnosis becomes highly important in the case of these diseases since the effective diagnosis depends on how many clear visuals are provided to the diagnostic expert thereby providing appropriate treatment, thus aiding the growth of the global optical biopsy market in the next five years.Increasing instances of stomach ulcers, stomach cancers, and growing demand for the surgical removal of cancerous cells from the inner and outer lining of the stomach also facilitates the growth of the global optical biopsy market in the future five years. In the year 2021, 2,281,658 new cancer cases surfaced in the United States alone. A surge in the demand from consumers for the surgical approach to cancer removal acts as a major factor fueling the growth of the global optical biopsy market in the forecast years.
Market Segmentation
The global optical biopsy market segmentation is based on technique, application, end-user, regional distribution, and competitive landscape. Based on technique, the market is fragmented into optical coherence tomography (OCT), laser, infrared, fluorescence, spectroscopy, and others. By application, the market is differentiated between oncological and non-oncological. Based on end users, the market is bifurcated into hospitals & clinics, cancer care centers, academic & research institutes, and others. The market analysis also studies the regional segmentation, divided among Asia-Pacific region, North American region, the Europe region, South American region, and the Middle East & African region.Company Profile
Vir Biotechnology, Inc., Mauna Kea Technologies SAS, SpectraScience, Inc., PENTAX Europe GmbH, Compact Imaging, Inc., NinePoint Medical, Inc., Precision Biopsy LLC, VivaScope GmbH, LighTopTech Corp., Scinvivo B.V., are enlisted in a partial list of major market players of the global optical biopsy market.Report Scope:
In this report, global optical biopsy market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:Optical Biopsy Market, By Technique:
- Optical Coherence Tomography (OCT)
- Laser
- Infrared
- Fluorescence
- Spectroscopy
- Others
Optical Biopsy Market, By Application:
- Oncological
- Non-Oncological
Optical Biopsy Market, By End User:
- Hospitals & Clinics
- Cancer Care Centers
- Academic & Research Institutes
- Others
Optical Biopsy Market, By Region:
- North America
- United States
- Mexico
- Canada
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- New Zealand
- Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
- Netherlands
- Denmark
- Ireland
- Belgium
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global optical biopsy market.Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.This product will be delivered within 1-3 business days.
Table of Contents
1. Product Overview2. Research Methodology3. Executive Summary4. Impact of COVID-19 on Global Optical Biopsy Market6. Clinical Trials Analysis7. Patent Analysis15. Market Trends & Developments17. Strategic Recommendations
5. Voice of Customer
8. Global Optical Biopsy Market Outlook
9. North America Optical Biopsy Market Outlook
10. Europe Optical Biopsy Market Outlook
11. Asia-Pacific Optical Biopsy Market Outlook
12. South America Optical Biopsy Market Outlook
13. Middle East and Africa Optical Biopsy Market Outlook
14. Market Dynamics
16. Competitive Landscape
Companies Mentioned
- Vir Biotechnology, Inc.
- Mauna Kea Technologies SAS
- SpectraScience, Inc.
- PENTAX Europe GmbH
- Compact Imaging, Inc.
- NinePoint Medical, Inc.
- Precision Biopsy LLC
- VivaScope GmbH
- LighTopTech Corp.
- Scinvivo B.V.